相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
Julia Seeger et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
Giulia Renda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
Raffaele De Caterina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Current status of transcatheter mitral valve therapy in Europe: results from an EAPCI survey (Part II)
Anna Sonia Petronio et al.
EuroIntervention (2017)
Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry
A. Vora et al.
INDIAN HEART JOURNAL (2017)
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Rick A. Nishimura et al.
CIRCULATION (2017)
Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves
Anthony P. Carnicelli et al.
CIRCULATION (2017)
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves A Meta-Analysis
Konstantinos C. Siontis et al.
CIRCULATION (2017)
Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves
Ajay Yadlapati et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial
Raffaele De Caterina et al.
EUROPACE (2016)
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Paulus Kirchhof et al.
EUROPACE (2016)
Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis
Zhe Xu et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)
Michael D. Ezekowitz et al.
CIRCULATION (2016)
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
Jan Beyer-Westendorf et al.
EUROPACE (2016)
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication
Andreas Goette et al.
EUROPACE (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPACE (2016)
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
Guenter Breithardt et al.
HEART (2016)
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Omar Abdul-Jawad Altisent et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
OUTCOMES IN 2824 PATIENTS WITH VALVULAR HEART DISEASE TREATED WITH EDOXABAN OR WARFARIN IN THE ENGAGE AF-TIMI 48 TRIAL
Giulia Renda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Economic evaluation of the new oral anticoagulants for the prevention of thromboembolic events: a cost-minimization analysis
Milena Soriano Marcolino et al.
SAO PAULO MEDICAL JOURNAL (2016)
Spotlight on unmet needs in stroke prevention: The PIONEER AF-PCI, NAVIGATE ESUS and GALILEO trials
Melanie Hemmrich et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project
Raphael Philippart et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Increased bleeding risk in patients with aortic valvular stenosis: From new mechanisms to new therapies
Joanna Natorska et al.
THROMBOSIS RESEARCH (2016)
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
Andre Rodrigues Duraes et al.
DRUGS IN R&D (2016)
Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement
Amjad I. Hussain et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Improving Clinical Practice Guidelines for Practicing Cardiologists
Jesaia Benhorin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
How to define valvular atrial fibrillation?
Laurent Fauchier et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2015)
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Alvaro Avezum et al.
CIRCULATION (2015)
Pregnancy in Women With a Mechanical Heart Valve Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC)
Iris M. van Hagen et al.
CIRCULATION (2015)
Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device
Leif I. Boesche et al.
CLINICAL CARDIOLOGY (2015)
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2015)
Management of valvular disease in pregnancy: a global perspective
Karen Sliwa et al.
EUROPEAN HEART JOURNAL (2015)
Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project
Raphael Philippart et al.
EUROPEAN HEART JOURNAL (2015)
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
Stefanie Schulz-Schuepke et al.
EUROPEAN HEART JOURNAL (2015)
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience
Matthew J. Price et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Non-valvular atrial fibrillation: potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants
Giuseppe Boriani et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2015)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves
R. R. Makkar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Philip Urban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Empirical relationships between health literacy and treatment decision making: A scoping review of the literature
Leslie J. Malloy-Weir et al.
PATIENT EDUCATION AND COUNSELING (2015)
Antithrombotic therapy in TAVI patients: changing concepts
Giuseppe Gargiulo et al.
EuroIntervention (2015)
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation
Iqbal H. Jaffer et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
Liesl Zuehlke et al.
EUROPEAN HEART JOURNAL (2015)
Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control
Andrej Janzic et al.
PHARMACOECONOMICS (2015)
Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries The RE-LY Atrial Fibrillation Registry
Jonas Oldgren et al.
CIRCULATION (2014)
Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
Sumeet S. Chugh et al.
CIRCULATION (2014)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Rick A. Nishimura et al.
CIRCULATION (2014)
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Gregory Y. H. Lip et al.
EUROPACE (2014)
The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey
Mauro Molteni et al.
EUROPACE (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
Gunter Breithardt et al.
EUROPEAN HEART JOURNAL (2014)
Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation
Jeroen J. Bax et al.
EUROPEAN HEART JOURNAL (2014)
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Gregory Y. H. Lip et al.
EUROPEAN HEART JOURNAL (2014)
What is 'valvular' atrial fibrillation? A reappraisal
Raffaele De Caterina et al.
EUROPEAN HEART JOURNAL (2014)
Futility, Benefit, and Transcatheter Aortic Valve Replacement
Brian R. Lindman et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Incidence and Cost of Stroke and Hemorrhage in Patients Diagnosed with Atrial Fibrillation in France
Francois-Emery Cotte et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Global epidemiology of atrial fibrillation
Faisal Rahman et al.
NATURE REVIEWS CARDIOLOGY (2014)
Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of these guidelines as an educational tool for neurologists
James F. Meschia et al.
STROKE (2014)
Atrial Fibrillation and Aortic Stenosis Impact on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation
Stefan Stortecky et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2013)
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association
Giuseppe Boriani et al.
EUROPEAN HEART JOURNAL (2013)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Atrial fibrillation prevalence revisited
L. Friberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
The Costs of Warfarin Underuse and Nonadherence in Patients with Atrial Fibrillation: A Commercial Insurer Perspective
Julian P. Casciano et al.
JOURNAL OF MANAGED CARE PHARMACY (2013)
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)
Vivek Y. Reddy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Willem J. M. Dewilde et al.
LANCET (2013)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
Charalampos Kasmeridis et al.
PHARMACOECONOMICS (2013)
Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement
John Webb et al.
CANADIAN JOURNAL OF CARDIOLOGY (2012)
The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Epidemiology of Atrial Fibrillation in Regions Outside North America and Europe
Gregory Y. H. Lip et al.
CHEST (2012)
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Richard P. Whitlock et al.
CHEST (2012)
Timing, Predictive Factors, and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation
Luis Nombela-Franco et al.
CIRCULATION (2012)
Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries, 1993-2007
Jonathan P. Piccini et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association
A. John Camm et al.
EUROPACE (2012)
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian et al.
EUROPEAN HEART JOURNAL (2012)
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2012)
Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding
Charlotte Merie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Transcatheter Valve Replacement for Aortic Stenosis Balancing Benefits, Risks, and Expectations
Chintan S. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Dabigatran versus Warfarin after Mechanical Mitral Valve Replacement in the Swine Model
John L. Schomburg et al.
JOURNAL OF INVESTIGATIVE SURGERY (2012)
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper
Raffaele De Caterina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement
David R. Holmes et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation
Catherine J. Mercaldi et al.
CARDIOLOGY RESEARCH AND PRACTICE (2012)
The cost of illness of atrial fibrillation: a systematic review of the recent literature
S. E. Wolowacz et al.
EUROPACE (2011)
Relation of the severity of mitral regurgitation to thromboembolic risk in patients with atrial fibrillation
Nobuyuki Fukuda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
Guillaume Cayla et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves
Stephen H. McKellar et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement
Ming-Feng Dong et al.
THROMBOSIS RESEARCH (2011)
Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement
Maggie N. Tillquist et al.
PATIENT PREFERENCE AND ADHERENCE (2011)
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the LOWERING-IT Trial
Michele Torella et al.
AMERICAN HEART JOURNAL (2010)
Balancing the Risk of Hemorrhage vs Thromboembolism in Patients With Atrial Fibrillation How To Navigate Between Scylla and Charybdis?
Giuseppe Boriani et al.
CHEST (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPACE (2010)
Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
Helmut Baumgartner et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2009)
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
Timothy Watson et al.
LANCET (2009)
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
David R. Holmes et al.
LANCET (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Valvular and structural heart disease
Deeb N. Salem et al.
CHEST (2008)
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Stuart J. Connolly et al.
CIRCULATION (2008)
Melagatran for thromboprophylaxis after mechanical valve implantation: Results in a heterotopic porcine model
Jess L. Thompson et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2007)
Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: A pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP)
Vittorio Pengo et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2007)
Combined antiplatelet and anticoagulant therapy: clinical benefits and risks
J. W. Eikelboom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Antiplatetet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors
Martin Brueck et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
The impact of atrial fibrillation on the cost of stroke:: The Berlin acute stroke study
Bernd Brueggenjuergen et al.
VALUE IN HEALTH (2007)
Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients
Francesco Dentali et al.
ANNALS OF INTERNAL MEDICINE (2007)
Recommendations for the management of patients after heart valve surgery
EG Butchart et al.
EUROPEAN HEART JOURNAL (2005)
Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac):: prospective, randomized, co-operative trial
JI Aramendi et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2005)
Should aspirin be continued in patients started on warfarin? A systematic review and meta-analysis
RJ Larson et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses
H Oxenham et al.
HEART (2003)
A prospective survey of patients with valvular heart disease in Europe:: The Euro Heart Survey on Valvular Heart Disease
B Iung et al.
EUROPEAN HEART JOURNAL (2003)
Prosthetic valve type for patients undergoing aortic valve replacement: A decision analysis
NJO Birkmeyer et al.
ANNALS OF THORACIC SURGERY (2000)
Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis - A clinical and transesophageal echocardiographic study
P Laffort et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
